Members of our division of Multiple Sclerosis and Neuroimmunology provides excellent patient care as well as clinical and basic research concerning immune diseases of the central nervous system. All of our providers have been named MS Certified Specialists by the Consortium of MS Centers.

Our providers have experience with a variety of injectable, oral, and infusion treatments for MS and in treating a variety of neuroimmunological conditions. They will work with you to find a therapy that meets your needs based on your symptoms and personal preferences.

Our clinic regularly participates in clinical trials to evaluate new treatments and treatment regimens for MS and other neuroimmunological conditions, including cyclosporine, beta-seron, avonex/rebif, and steroids for optic neuritis. Finally, we are an integral part of the Duke Center for Research in Autoimmunity and Multiple Sclerosis (DREAMS), a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune diseases.

Duke Neurology Research Round Up, September 2021

Members of the Duke Neurology Department contributed to seventeen peer-reviewed research studies published this August. Members of the lab of Nicole Calakos, MD, PhD, discovered that a medication created to treat patients with HIV may help people with dystonia. New translational research provided the most accurate atlas of the mouse model to date and answered questions about late-onset Alzheimer’s disease.

Duke Neurology Research Round Up, June 2021

Members of the Duke Neurology Department did their part for Stroke Awareness Month, contributing to eight new peer-reviewed studies published this May. But our other divisions didn’t hold back either, with thirteen other articles advancing our understanding of neuro-oncology, multiple sclerosis, headache, and other subjects.

Read about each of the studies published from members of the Duke Neurology Department below, and find links to the original journal articles as well.



Duke Neurology at AAN 2021: Highlights from a virtual year

The American Academy of Neurology (AAN) has moved its annual meeting to a virtual setting this year, but its offerings of the latest education and scientific programming continue. This year, members of the Duke Neurology Department collaborated with their colleagues at Duke and with other academic institutions to advance our understanding of neuro-oncology, myasthenia gravis, ALS, and other fields and disciplines. 

Duke Neurology Research Round Up, April 2021

Members of the Duke Neurology Department contributed to 21 new studies in peer-reviewed journals this March, advancing our ability to understand, treat, and prevent diseases and conditions from across the field of neurology. Brian Mac Grory, MB BCh, MRCP, and other members of our stroke and vascular neurology helped answer questions about the best way to treat patients who have a stroke in their sleep.

Duke Neurology Research Round Up, January 2021

The final month of 2020 saw fifteen new publications written or co-written by members of the Duke Department of Neurology. Sneha Mantri, MD, MS, was a lead author of a new study examining factors contributing to burnout and moral injury among health-care workers at Duke. Our Neuromuscular Disease faculty wrote multiple studies advancing our understanding of myasthenia gravis, including how the COVID-19 pandemic is affecting people with this condition. Other articles answered questions about stroke, Parkinson’s, and other diseases.

Duke Neurology Research Round Up, December 2020

This November, research from members of the Duke Department of Neurology examined how different types of seizures feel to the person experiencing them, discovered genes associated with longevity and health cognition, analyzed how the COVID-19 outbreak impacted stroke care, and more. Our faculty, trainees, and staff contributed to 15 studies published in the past 30 days. Read about each of them, and find links to the original articles below. 


Multiple Sclerosis and Neuroimmunology

Faculty Spotlight: Dorlan Kimbrough, MD

For Dorlan Kimbrough, MD, neurology is both an intellectual challenge and a moral calling, or in his words, “a puzzle that matters.” For this week’s “Spotlight” interview, the new member of our faculty talks about balancing his work diagnosing and treating patients with neuroimmunological conditions while conducting clinical research to improve treatment for those conditions. He also discusses the medical community’s success in treating multiple sclerosis over the past 20 years, his own career path to neurology, and enjoying music, running, and chess in his spare time.

Duke Neurology Research Round Up, August 2020

Members of the Duke Neurology Department contributed to 14 new peer-reviewed articles published this July, improving our understanding of neuroscience, charting a course for research in a post-COVID-19 world, and offering opportunities for advancing patient care. Simon Gregory, PhD, and Yong Chen, PhD, respectively co-authored articles offering new therapeutic avenues for muscle repair and chronic pain treatment. Wuwei “Wayne” Feng, MD, MS, was part of a consortium examining the impact of COVID-19 on the NIH’s StrokeNet and offering a vision for resuming clinical trials.

Duke Neurology Research Round Up, July 2020

New research from the Duke Neurology Department advanced our understanding of neurological diseases and patient care at the basic science, translational, and clinical levels. Among other topics, our faculty, trainees, and staff found evidence for virtual reality’s potential in neurorehabilitation, tested a wearable device that can help better identify seizures, and reviewed how our understanding of the hippocampus has evolved over the past generation. Read the short paragraphs below to learn more about these and other topics, and find links to the original journal articles themselves.